The latest #FDA guidance on in vitro drug-drug interactions is finally out!
The latest #FDA guidance on in vitro drug-drug interactions is finally out!
The latest #FDA guidance on in vitro drug-drug interactions is finally out!
linkedin

Among other things, the agency explains that DDIs are a critical factor in a drug’s overall benefit-risk profile. The results of in vitro DDI studies and pharmacokinetic (PK) data “provide mechanistic information that can inform the need for and proper design of potential future clinical studies.”

More information here.

Comments are disabled